請更新您的瀏覽器

您使用的瀏覽器版本較舊,已不再受支援。建議您更新瀏覽器版本,以獲得最佳使用體驗。

Eng

Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)

PR Newswire (美通社)

更新於 2024年10月08日02:15 • 發布於 2024年10月08日02:00 • PR Newswire

BEIJING and HANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- The 32nd United European Gastroenterology Week (UEG Week 2024) will take place in Vienna, Austria, from October 12 to 15, 2024. UEG Week is the largest gastroenterology conference in Europe and one of the leading meetings worldwide. It brings together gastroenterology experts, physicians, researchers, and industry representatives from around the globe to share the latest research advances, clinical practices, and treatment solutions. Sciwind Biosciences Co., Ltd. will present the latest research progress on an oral, long-acting glucagon-like peptide 2 (GLP-2) for the treatment of short bowel syndrome in an oral presentation.

Details of the oral presentation are as follows:

Title: Discovery of an Oral, Long-Acting Glucagon-Like Peptide 2 as Best-in-Class Treatment for Short Bowel Syndrome (#OP160)

Presenter: Haixia Zou, PhD

Session Name: Short bowel syndrome

Session Time/Date: 08:30 am - 09:30 am, Oct 15, 2024,

Session Room: Lehar 1

Presentation Number: OP160

About GLP-2 and Short Bowel Syndrome

GLP-2 is a peptide hormone secreted by the intestine and belongs to the glucagon family. It is primarily secreted by L cells in the intestine after meals. Its main functions include promoting intestinal growth, repair, and nutrient absorption, as well as regulating gastrointestinal function. Short bowel syndrome is a malabsorption syndrome caused by a significant reduction in the length of the small intestine. The main characteristic of this condition is the body's inability to absorb nutrients, fluids, and electrolytes properly due to the partial or total loss of small intestinal function. This condition is often caused by surgical resection, congenital defects, or intestinal disease. It severely impacts patients' quality of life, leading to malnutrition, weight loss, chronic diarrhea, and other complications. Currently, injectable GLP-2 analogs are approved for the treatment of short bowel syndrome, and the development of an oral, long-acting GLP-2 molecule would greatly improve patient compliance and convenience.

About Sciwind Biosciences

Sciwind Biosciences is a clinical stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease. Its product pipeline consists of potentially first-in-class and best-in-class drug candidates, including the long-acting GLP-1 peptide analog XW003 (Phase 3), oral GLP-1 peptide analog XW004 (Phase 1), an oral small molecule GLP-1 receptor agonist XW014 (Phase 1), and novel amylin analogs (preclinical). Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms and identified a series of drug candidates based on these core platform technologies. For more information, visit .

查看原始文章

ROSHI Unveils Comprehensive Report on the Future of Digital Lending, Highlighting Global Trends for 2025 and Beyond

PR Newswire (美通社)

TECNO and Lay Zhang Jointly Launch "Unstoppable Step" Film, Encouraging SEA Youngsters to Harness the Power of Every Step that Counts for Better Self

PR Newswire (美通社)

Empowering Elder Care: DKSH's Mission for "Patient Purpose Day 2024"

PR Newswire (美通社)
查看更多
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

留言 0

沒有留言。

最新內容

Strong, practical relations with China positively impact Rwandan people: FM

XINHUA

China will continue being an important driving force for global connectivity: foreign ministry

XINHUA

Update: Typhoon Wutip makes landfall in China's Hainan

XINHUA

Southern China on high alert as Typhoon Wutip makes landfall

XINHUA

Column: America's "Golden Dome": a futile attempt with no winners

XINHUA

Iranian president vows "powerful" response to Israeli strikes

XINHUA

VIVOTEK Earned Level 2 in TWSE's 11th Corporate Governance Evaluation, Top 5% Among NT$5-10B Cap Enterprises

PR Newswire (美通社)

Xinhua Headlines: Israeli attacks on Iran raises risk of regional conflict

XINHUA

Typhoon Wutip makes landfall in China's Hainan

XINHUA

New image of "Made-in-China" captures hearts around the world

XINHUA

China dominates 1st day of World Aquatics Artistic Swimming World Cup 2025 Super Final

XINHUA

SCO members discuss sci-tech cooperation

XINHUA

Anytime Fitness Asia Launches Its Biggest-Ever Regional Brand Campaign - "Train For Your Life"

PR Newswire (美通社)

2025 Land-Sea Economic Forum Drives China-ASEAN Industrial Cooperation

PR Newswire (美通社)

Update: People evacuated, flights canceled as south China braces for Typhoon Wutip

XINHUA

"Please, let me save just one more"

XINHUA

Israeli strikes on Iran prompt widespread condemnation in Middle East

XINHUA

China moves to curb misconduct in healthcare sector

XINHUA

New Chinese database bridges global gaps in plant trait data

XINHUA

Mainland slams DPP for manipulation of judiciary to suppress mainland ship captain

XINHUA

Xinhua Headlines: From internet to reality, foreign influencers see a vibrant China

XINHUA

Explainer: What is known about Air India plane crash?

XINHUA

Local media report says 1 black box of crashed Air India plane found

XINHUA

TGE Pioneers an Iconic Fashion Show at the New York Stock Exchange's Trading Floor

PR Newswire (美通社)

China's delicate waxberries go global with smart logistics support

XINHUA

MEXC Launches Golden Era Showdown Mid-Year Trading Event with a 10 Million USDT Prize Pool

PR Newswire (美通社)

On-site report: escalation between Israel, Iran

XINHUA

WorldInFocus | Five Central Asian countries in a glance

XINHUA

27th Shanghai International Film Festival Kicks Off with a Wave of Chinese Cinema

PR Newswire (美通社)

Revised edition of Chen Yun's works published to mark 120th birth anniversary

XINHUA

Mainland slams DPP for blocking cross-Strait exchanges

XINHUA

Chinese premier chairs meeting on pilot free trade zone, real estate

XINHUA

Beijing braces for heavy rainfall

XINHUA

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

PR Newswire (美通社)

Xinhua Commentary: China-Africa partnership an unshakable bond

XINHUA

The Warmth of Dialogue Between Civilizations -- A 700-Year Journey of Shared Aspirations

PR Newswire (美通社)

Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD'

PR Newswire (美通社)

Xi urges hard work to build strong China as CPC marks 120th birth anniversary of veteran leader Chen Yun

XINHUA

Ping An Ranks 27th on Forbes' Global 2000 List

PR Newswire (美通社)

"Hong Kong ACTION" Officially Launched, GAC Group Showcased Technological Ecosystem Product Matrix at 2025 International Automotive & Supply Chain Expo (Hong Kong)

PR Newswire (美通社)